SEC Tracker
Get the app

Greenpro Capital GRNQ

Greenpro Capital FY 2025: revenue $2.1M, down 41%; diluted EPS −$0.37

Form
10-K
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Greenpro Capital reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$2.1M−41% from $3.5M in FY 202410-K income statement, on EDGAR
  2. Net income−$3.0MAgainst −$715K in FY 202410-K income statement, on EDGAR
  3. Diluted EPS−$0.37Against −$0.09 in FY 202410-K income statement, on EDGAR
  4. Cash and cash equivalents$637K−43% from $1.1M in FY 202410-K balance sheet, on EDGAR
  5. Cash from operations−$1.8MAgainst −$1.4M in FY 202410-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Greenpro Capital files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.

  1. Aeries Technology AERT public float $8M, Sep 30, 2025
  2. Elvictor Group ELVG public float $8M, Jun 30, 2025
  3. RTB Digital RTB public float $9M, Jun 30, 2025
  4. Panamera Holdings PHCI public float $12M, Jan 31, 2025, over 18 months old
  5. Pharma-Bio Serv PBSV public float $14M, Apr 30, 2025, over 18 months old